LDN-57444 |
|
27706-1 |
BPS Bioscience |
10 mg |
EUR 180 |
|
Description: LDN-57444 is a cell permeable ubiquitin C-terminal hydrolase (UCH-L1) inhibitor (Ki=0.4 µM). Decreases proteasome activity and increases levels of ubiquitinated proteins. Induces apoptosis and causes dramatic alterations in synaptic protein distribution and spine morphology in vivo. LDN-57444 is a useful tool to study UCH-L1 in different pathological conditions such as cancer and neurodegeneration. |
Human IgG antibody Laboratories manufactures the tsh elisa rat ldn reagents distributed by Genprice. The Tsh Elisa Rat Ldn reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact tsh elisa. Other Tsh products are available in stock. Specificity: Tsh Category: Elisa Group: Rat Ldn
LDN-212854 |
|
ApexBio |
50 mg |
EUR 1062 |
|
Description: LDN-212854 is a selective inhibitor of bone morphogenetic protein (BMP) signaling with IC50 value of 1.2nM [1].In the kinase assay, LDN-212854 shows inhibitory activities against caALK2 and caALK5 with IC50 values of 16nM and 2?M, respectively. |
LDN-27219 |
|
ApexBio |
10 mg |
EUR 334.8 |
|
Description: LDN-27219 is a reversible and slow-binding inhibitor of tissue transglutaminase (TGases) with IC50 value of 250nM for TGase 2 [1, 2].LDN-27219 is discovered as a moderately potent inhibitor of TGase. |
LDN-27219 |
|
ApexBio |
10 mM (in 1mL DMSO) |
EUR 362.4 |
|
Description: LDN-27219 is a reversible and slow-binding inhibitor of tissue transglutaminase (TGases) with IC50 value of 250nM for TGase 2 [1, 2].LDN-27219 is discovered as a moderately potent inhibitor of TGase. |
LDN-27219 |
|
ApexBio |
50 mg |
EUR 1221.6 |
|
Description: LDN-27219 is a reversible and slow-binding inhibitor of tissue transglutaminase (TGases) with IC50 value of 250nM for TGase 2 [1, 2].LDN-27219 is discovered as a moderately potent inhibitor of TGase. |
Rat Ldn information
Ldn-57444 |
|
abx188748-1g |
Abbexa |
1 g |
EUR 1680 |
|
|
LDN-27219 |
|
B5652-10 |
ApexBio |
10 mg |
EUR 334.8 |
|
Description: LDN-27219 is a reversible and slow-binding inhibitor of tissue transglutaminase (TGases) with IC50 value of 250nM for TGase 2 [1, 2].LDN-27219 is discovered as a moderately potent inhibitor of TGase. |
LDN-27219 |
|
B5652-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 362.4 |
|
Description: LDN-27219 is a reversible and slow-binding inhibitor of tissue transglutaminase (TGases) with IC50 value of 250nM for TGase 2 [1, 2].LDN-27219 is discovered as a moderately potent inhibitor of TGase. |
LDN-27219 |
|
B5652-50 |
ApexBio |
50 mg |
EUR 1221.6 |
|
Description: LDN-27219 is a reversible and slow-binding inhibitor of tissue transglutaminase (TGases) with IC50 value of 250nM for TGase 2 [1, 2].LDN-27219 is discovered as a moderately potent inhibitor of TGase. |
LDN-57444 |
|
27706-1 |
BPS Bioscience |
10 mg |
EUR 180 |
|
Description: LDN-57444 is a cell permeable ubiquitin C-terminal hydrolase (UCH-L1) inhibitor (Ki=0.4 µM). Decreases proteasome activity and increases levels of ubiquitinated proteins. Induces apoptosis and causes dramatic alterations in synaptic protein distribution and spine morphology in vivo. LDN-57444 is a useful tool to study UCH-L1 in different pathological conditions such as cancer and neurodegeneration. |
LDN-57444 |
|
27706-2 |
BPS Bioscience |
50 mg |
EUR 460 |
|
Description: LDN-57444 is a cell permeable ubiquitin C-terminal hydrolase (UCH-L1) inhibitor (Ki=0.4 µM). Decreases proteasome activity and increases levels of ubiquitinated proteins. Induces apoptosis and causes dramatic alterations in synaptic protein distribution and spine morphology in vivo. LDN-57444 is a useful tool to study UCH-L1 in different pathological conditions such as cancer and neurodegeneration. |
LDN 212320 |
|
B5805-10 |
ApexBio |
10 mg |
EUR 205.2 |
LDN 212320 |
|
B5805-25 |
ApexBio |
25 mg |
EUR 386.4 |
LDN 212320 |
|
B5805-5 |
ApexBio |
5 mg |
EUR 141.6 |
LDN 212320 |
|
B5805-50 |
ApexBio |
50 mg |
EUR 632.4 |
